Literature DB >> 12033772

Presence of Intact vpu and nef genes in nonpathogenic SHIV is essential for acquisition of pathogenicity of this virus by serial passage in macaques.

Glenn A Mackay1, Yafen Niu, Zhen Qian Liu, Sampa Mukherjee, Zhuang Li, Istvan Adany, Shilpa Buch, Wu Zhuge, Harold M McClure, Opendra Narayan, Marilyn S Smith.   

Abstract

Use of the macaque model of human immunodeficiency virus (HIV) pathogenesis has shown that the accessory genes nef and vpu are important in the pathogenicity of simian immunodeficiency virus (SIV) and simian-human immunodeficiency virus (SHIV). We examined the ability of two nonpathogenic SHIVs, SHIV(PPC) and DeltavpuDeltanefSHIV(PPC), to gain pathogenicity by rapid serial passage in macaques. In this study, each virus was passaged by blood intravenously four times at 4-week intervals in macaques. Animals were monitored for 40 weeks for levels of CD4 T cells and quantitative measures of virus infection. DeltavpuDeltanefSHIV(PPC) maintained a limited phase of productive replication in the four animals, with no loss of CD4(+) T cells, whereas SHIV(PPC) became more pathogenic in later passages, judging by plasma viral load and viral mRNA in lymph nodes, infectious peripheral blood mononuclear cells and CD4(+) T cell loss. The nef, LTR, and env of the SHIV(PPC) viruses underwent numerous mutations, compared to DeltavpuDeltanefSHIV(PPC). This study confirms the seminal role that nef, LTR, and vpu could play in regulation of pathogenesis of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033772     DOI: 10.1006/viro.2002.1368

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Protection of macaques against AIDS with a live attenuated SHIV vaccine is of finite duration.

Authors:  Anil Kumar; Zhenqian Liu; Darlene Sheffer; Marilyn Smith; Dinesh K Singh; Shilpa Buch; Opendra Narayan
Journal:  Virology       Date:  2007-11-07       Impact factor: 3.616

Review 2.  Is the high virulence of HIV-1 an unfortunate coincidence of primate lentiviral evolution?

Authors:  Frank Kirchhoff
Journal:  Nat Rev Microbiol       Date:  2009-03-23       Impact factor: 60.633

3.  Resources, mortality, and disease ecology: Importance of positive feedbacks between host growth rate and pathogen dynamics.

Authors:  Val H Smith; Robert D Holt; Marilyn S Smith; Yafen Niu; Michael Barfield
Journal:  Isr J Ecol Evol       Date:  2015-04-17       Impact factor: 0.559

4.  Characterization of a novel vpu-harboring simian immunodeficiency virus from a Dent's Mona monkey (Cercopithecus mona denti).

Authors:  Marie-Christine Dazza; Michel Ekwalanga; Monique Nende; Karhemere Bin Shamamba; Pitchou Bitshi; Dimitrios Paraskevis; Sentob Saragosti
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.

Authors:  Dinesh K Singh; Zhenqian Liu; Darlene Sheffer; Glenn A Mackay; Marilyn Smith; Sukhbir Dhillon; Ramakrishna Hegde; Fenglan Jia; Istvan Adany; Opendra Narayan
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Vpr and Vpu are important for efficient human immunodeficiency virus type 1 replication and CD4+ T-cell depletion in human lymphoid tissue ex vivo.

Authors:  Elke Rücker; Jean-Charles Grivel; Jan Münch; Frank Kirchhoff; Leonid Margolis
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Evidences for viral strain selection in late stages of HIV infection: an analysis of Vpu alleles.

Authors:  Marcos Vinícius Pereira Gondim; Joaquim Xavier da Silva; Francisco Prosdocimi; Eduardo Leonardecz-Neto; Octávio Luiz Franco; Enrique Roberto Argañaraz
Journal:  Protein J       Date:  2012-02       Impact factor: 2.371

8.  The vpu protein of human immunodeficiency virus type 1 plays a protective role against virus-induced apoptosis in primary CD4(+) T lymphocytes.

Authors:  Satoshi Komoto; Shoutaro Tsuji; Madiha S Ibrahim; Yong-Gang Li; Jiranan Warachit; Koki Taniguchi; Kazuyoshi Ikuta
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Longitudinal study to assess the safety and efficacy of a live-attenuated SHIV vaccine in long term immunized rhesus macaques.

Authors:  Thomas M Yankee; Darlene Sheffer; Zhengian Liu; Sukhbir Dhillon; Fenglan Jia; Yahia Chebloune; Edward B Stephens; Opendra Narayan
Journal:  Virology       Date:  2008-11-05       Impact factor: 3.616

Review 10.  Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model.

Authors:  Richard J Noel; Vanessa Rivera-Amill; Shilpa Buch; Anil Kumar
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.